Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ADMS
Delisted

Adamas Pharmaceuticals Stock Price (Quote)

$8.22
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $8.22 $8.22 Friday, 27th May 2022 ADMS stock ended at $8.22. During the day the stock fluctuated 0% from a day low at $8.22 to a day high of $8.22.
90 days $8.22 $8.22
52 weeks $4.02 $8.25

Historical Adamas Pharmaceuticals prices

Date Open High Low Close Volume
Nov 04, 2016 $13.93 $13.93 $13.93 $13.93 303 800
Nov 03, 2016 $12.24 $12.24 $12.24 $12.24 229 200
Nov 02, 2016 $13.56 $13.56 $13.56 $13.56 87 300
Nov 01, 2016 $14.00 $14.00 $14.00 $14.00 104 100
Oct 31, 2016 $13.74 $13.74 $13.74 $13.74 169 800
Oct 28, 2016 $13.71 $13.71 $13.71 $13.71 155 900
Oct 27, 2016 $14.33 $14.33 $14.33 $14.33 115 700
Oct 26, 2016 $14.35 $14.35 $14.35 $14.35 83 100
Oct 25, 2016 $14.52 $14.52 $14.52 $14.52 72 400
Oct 24, 2016 $14.51 $14.51 $14.51 $14.51 111 300
Oct 21, 2016 $14.59 $14.59 $14.59 $14.59 91 600
Oct 20, 2016 $14.55 $14.55 $14.55 $14.55 103 300
Oct 19, 2016 $14.24 $14.24 $14.24 $14.24 98 400
Oct 18, 2016 $14.68 $14.68 $14.68 $14.68 106 000
Oct 17, 2016 $14.52 $14.52 $14.52 $14.52 240 800
Oct 14, 2016 $14.45 $14.45 $14.45 $14.45 170 400
Oct 13, 2016 $15.10 $15.10 $15.10 $15.10 117 000
Oct 12, 2016 $15.25 $15.25 $15.25 $15.25 166 200
Oct 11, 2016 $15.95 $15.95 $15.95 $15.95 170 600
Oct 10, 2016 $16.61 $16.61 $16.61 $16.61 172 900
Oct 07, 2016 $15.94 $15.94 $15.94 $15.94 170 300
Oct 06, 2016 $16.00 $16.00 $16.00 $16.00 137 800
Oct 05, 2016 $16.60 $16.60 $16.60 $16.60 150 400
Oct 04, 2016 $16.38 $16.38 $16.38 $16.38 140 600
Oct 03, 2016 $16.42 $16.42 $16.42 $16.42 192 600
Click to get the best stock tips daily for free!

About Adamas Pharmaceuticals

Adamas Pharmaceuticals Adamas Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The company’s lead product candidate is the ADS-5102 that is in Phase 3 clinical development for the treatment of levodopa-induced dyskinesia, a movement disorder associated with Parkinson’s disease; and in a Phase 2 clinical study for the treatment of symptoms assoc... ADMS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT